incretin mimetic agents glp 1 receptor agonists Effects of incretin-based therapies on bone metabolism. GLP-1 GLP1 Receptor Agonists—Effects beyond Obesity

Ozempic and Zepbound both contain the active ingredient semaglutide, which is a GLP-1 receptor agonist

We specified and emulated eight target trials to address the aims of this study

doi: 10.1159/000521264 Summary Keywords GLP-1R agonists, obesity, weight-reducing drugs, metabolic diseases, dual agonism Citation Wang J-Y, Wang Q-W, Yang X-Y, Yang W, Li D-R, Jin J-Y, Zhang H-C and Zhang X-F (2023) GLP1 receptor agonists for the treatment of obesity: Role as a promising approach

[10] That's a pretty big incidence rate

As mentioned before, GLP-1R stimulation is able to reduce 6-OHDA-induced cell death in SH-SY5Y cells 62 as well as primary ventral mesencephalic (DAergic) neurons